Ocugen (NASDAQ:OCGN) Given Buy Rating at Chardan Capital
Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Chardan Capital in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $7.00 price target on the stock. Separately, HC Wainwright reduced their target price on Ocugen from $8.00 to $7.00 and set […]
